Number of the records: 1
Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours
Title Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours Author Čierna Zuzana Co-authors Miškovská V. Roška Jan SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Jurkovičová Dana 1973- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV ORCID Borszéková Pulzová Lucia SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Šestáková Zuzana 1983- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV ORCID Hurbanová Lenka SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Machaleková K. Chovanec Michal Rejleková Katarína Svetlovská D. Kaľavská Katarína 1987- Kajo Karol ORCID Babál Pavel Mardiak Jozef Ward Thomas A. Mego Michal SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Chovanec Miroslav 1969- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Source document BMC Cancer. Vol. 20, no. 1 (2020), art.no. 17 Language eng - English Note open access URL URL link Document kind rozpis článkov z periodík (rbx) Citations DUAN, M.R. - ULIBARRI, J. - LIU, K.J. - MAO, P. Role of Nucleotide Excision Repair in Cisplatin Resistance. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. DEC 2020, vol. 21, no. 23. CARDOSO, A.R. - LOBO, J. - MIRANDA-GONCALVES, V. - HENRIQUE, R. - JERONIMO, C. Epigenetic alterations as therapeutic targets in Testicular Germ Cell Tumours : current and future application of 'epidrugs'. In EPIGENETICS. ISSN 1559-2294, APR 3 2021, vol. 16, no. 4, p. 353-372. LOBO, J. - JERONIMO, C. - HENRIQUE, R. Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives. In CANCERS. JUN 2020, vol. 12, no. 6. SKOWRON, M.A. - OING, C. - BREMMER, F. - STROBEL, P. - MURRAY, M.J. - COLEMAN, N. - AMATRUDA, J.F. - HONECKER, F. - BOKEMEYER, C. - ALBERS, P. - NETTERSHEIM, D. The developmental origin of cancers defines basic principles of cisplatin resistance. In CANCER LETTERS. ISSN 0304-3835, OCT 28 2021, vol. 519, p. 199-210. WENMAEKERS, S. - VIERGEVER, B.J. - KUMAR, G. - KRANENBURG, O. - BLACK, P.C. - DAUGAARD, M. - MEIJER, R.P. A Potential Role for HUWE1 in Modulating Cisplatin Sensitivity. In CELLS. MAY 2021, vol. 10, no. 5. SINGH, R. - FAZAL, Z. - FREEMANTLE, S.J. - SPINELLA, M.J. Between a Rock and a Hard Place: An Epigenetic-Centric View of Testicular Germ Cell Tumors. In CANCERS. APR 2021, vol. 13, no. 7. ZHANG, Y. - WEI, W. - LI, C.Y. - YAN, S.Y. - WANG, S.S. - XIAO, S.D. - HE, C.C. - LI, J. - QI, Z. - LI, B.Y. - YANG, K. - LI, C.L. Idarubicin combats abiraterone and enzalutamide resistance in prostate cells via targeting XPA protein. In CELL DEATH & DISEASE. ISSN 2041-4889, DEC 12 2022, vol. 13, no. 12. Dostupné na: https://doi.org/10.1038/s41419-022-05490-5. CAHUZAC, M. - PEANT, B. - MES-MASSON, A.M. - SAAD, F. Development of Olaparib-Resistance Prostate Cancer Cell Lines to Identify Mechanisms Associated with Acquired Resistance. In CANCERS. AUG 2022, vol. 14, no. 16. Dostupné na: https://doi.org/10.3390/cancers14163877. DAI, W.M. - WU, A. - LI, Y.P. - YU, G.F. - YAN, X.J. XPA Enhances Temozolomide Resistance of Glioblastoma Cells by Promoting Nucleotide Excision Repair. In CELL TRANSPLANTATION. ISSN 0963-6897, MAY 2022, vol. 31. Dostupné na: https://doi.org/10.1177/09636897221092778. SUZUKI, T. - SIRIMANGKALAKITTI, N. - BABA, A. - TOYOSHIMA-NAGASAKI, R. - ENOMOTO, Y. - SAITO, N. - OGASAWARA, Y. Characterization of the nucleotide excision repair pathway and evaluation of compounds for overcoming the cisplatin resistance of non-small cell lung cancer cell lines. In ONCOLOGY REPORTS. ISSN 1021-335X, APR 2022, vol. 47, no. 4. Dostupné na: https://doi.org/10.3892/or.2022.8281. LIU, C.F. - ZHOU, S.J. - BAI, W.B. - SHI, L. - LI, X.L. Protective effect of food derived nutrients on cisplatin nephrotoxicity and its mechanism. In FOOD & FUNCTION. ISSN 2042-6496, MAY 10 2022, vol. 13, no. 9, p. 4839-4860. Dostupné na: https://doi.org/10.1039/d1fo04391a. LI, H.W. - YANG, D.H. - XU, Z.M. - YANG, L. - LIN, J. - CAI, J.Y. - YANG, L. Metformin Sensitizes Cisplatin-induced Apoptosis Through Regulating Nucleotide Excision Repair Pathway In Cisplatin-resistant Human Lung Cancer Cells. In LETTERS IN DRUG DESIGN & DISCOVERY. ISSN 1570-1808, 2022, vol. 19, no. 12, p. 1086-1095. Dostupné na: https://doi.org/10.2174/1570180819666220330121135. Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2020 Registered in WOS Registered in SCOPUS Registered in CCC DOI 10.1186/s12885-019-6496-1 
article
File name Access Size Downloaded Type License Increased levels of XPA might be the basis.pdf available 1.1 MB 4 Publisher's version rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2020 2019 3.150 Q3 1.186 Q2
Number of the records: 1